000			01913 a2200481 4500
005			20250515013208.0
264		0	_c20060324
008			200603s 0 0 eng d
022			_a0022-1767
024	7		_a10.4049/jimmunol.176.3.1447 _2doi
040			_aNLM _beng _cNLM
100	1		_aDolan, Brian P
245	0	0	_aTumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 2006
300			_a1447-55 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntigen Presentation _ximmunology
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCancer Vaccines _xadministration & dosage
650	0	4	_aCell Communication _ximmunology
650	0	4	_aCells, Cultured
650	0	4	_aDendritic Cells _ximmunology
650	0	4	_aEpitopes, T-Lymphocyte _ximmunology
650	0	4	_aFemale
650	0	4	_aHistocompatibility Antigens Class I _ximmunology
650	0	4	_aHistocompatibility Antigens Class II _xadministration & dosage
650	0	4	_aLymphocyte Activation _ximmunology
650	0	4	_aLymphoma, B-Cell _ximmunology
650	0	4	_aMale
650	0	4	_aMelanoma, Experimental _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred A
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aMice, Transgenic
650	0	4	_aNecrosis
650	0	4	_aTumor Cells, Cultured
700	1		_aGibbs, Kenneth D
700	1		_aOstrand-Rosenberg, Suzanne
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 176 _gno. 3 _gp. 1447-55
856	4	0	_uhttps://doi.org/10.4049/jimmunol.176.3.1447 _zAvailable from publisher's website
999			_c16039909 _d16039909